Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
12.45
-2.05 (-14.14%)
At close: Nov 20, 2024, 4:00 PM
13.07
+0.62 (4.98%)
After-hours: Nov 20, 2024, 4:08 PM EST
Zenas BioPharma Market Cap
Zenas BioPharma has a market cap or net worth of $520.30 million as of November 21, 2024.
Market Cap
520.30M
Enterprise Value
133.88M
1-Year Change
n/a
Ranking
Category
Stock Price
Market Cap Chart
Since the IPO on September 13, 2024, Zenas BioPharma's market cap has decreased from $676.47M to $520.30M, a decrease of -23.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 605.97M | -10.42% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EyePoint Pharmaceuticals | 639.16M |
| Oculis Holding AG | 636.31M |
| Tourmaline Bio | 631.19M |
| Entrada Therapeutics | 630.92M |
| Ironwood Pharmaceuticals | 627.31M |
| Stoke Therapeutics | 621.30M |
| Exscientia | 620.34M |
| ORIC Pharmaceuticals | 614.99M |